Rina-S: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

15

Conditions studied

25

US states with sites

12

Countries

Phase breakdown

Phase 1 1 Phase 2 2

Conditions being studied

Condition	Trials
Lung cancer	2
Breast Adenocarcinoma	1
Breast cancer	1
Endometrial Cancer	1
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)	1
Fallopian Tube Cancer	1
High Grade Epithelial Ovarian Cancer	1
High Grade Serous Ovarian Cancer	1
Hormone Receptor-positive/Her2 Negative Breast Cancer	1
Mesothelioma	1
Non-small Cell Lung Cancer	1
Non-small Cell Lung Cancer (NSCLC)	1
Platinum Sensitive Ovarian Cancer (PSOC)	1
Platinum-resistant Ovarian Cancer (PROC)	1
Primary Peritoneal Carcinoma	1

Recruiting trials involving Rina-S

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 66 locations
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
NCT07288177 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 57 locations

Common questions

How many recruiting trials involve Rina-S?

2 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.